2017 annual financial data
Alnylam Pharmaceuticals 2017 Operating margin
Alnylam Pharmaceuticals 2017 operating margin with verified reported values.
Direct answer
Operating margin was -556.2%.
Operating income was -500,088,000 USD and net income was -490,874,000 USD.
Operating cash flow was -382,786,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 89,912,000 USD
- Operating income
- -500,088,000 USD
- Net income
- -490,874,000 USD
- Operating cash flow
- -382,786,000 USD